Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a devastating brain disorder clinically characterised by progressive loss of characteristic cognitive abilities. Increasing evidence suggests a disturbed copper (Cu) homeostasis to be associated with the pathological processes. In the present study we analysed the plasma Cu levels and cognitive abilities using the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-cog) in 32 patients with mild to moderate AD. Statistical analysis revealed a negative correlation between plasma Cu levels and cognitive decline (r=-0.49; P<0.01). Patients with low plasma Cu (mean 82 +/- SD 9) had significant higher ADAS-cog values (mean 23 +/- SD 7), than patients with medium plasma Cu (mean 110 +/- SD 7), who exhibited lower ADAS-cog scores (mean 16 +/- SD 4; ANOVA, P<0.0001). Despite the fact that all patients had plasma Cu levels within the physiological range between 65 microg and 165 microg/dL, 87.5% of the patients revealed a significant negative correlation between plasma Cu and ADAS-cog. This finding supports the hypothesis of a mild Cu deficiency in most AD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“uble brain Cu and Zn levels [8].”
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · cited 1×
“When AD patients were treated with clioquinol, the placebo group deteriorated faster than the clioquinol group suggesting a beneficial effect upon clioquinol treatment [15].”
The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Self-citationAtwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
White, A. R., Reyes, R., Mercer, J. F. B., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01861-2 · Cited by 282
Self-citationStructure of the Alzheimer's Disease Amyloid Precursor Protein Copper Binding Domain
Barnham, K. J., McKinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., Williamson, N. A., White, A. R., Hinds, M. G., Norton, R. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300629200 · Cited by 275
Self-citationThe βA4 amyloid precursor protein binding to copper
Hesse, L., Beher, D., Masters, C. L., & Multhaup, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00658-x · Cited by 248
Self-citation
Cited by
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
Copper in the brain and Alzheimer’s disease
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 498
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Risks of Copper and Iron Toxicity during Aging in Humans
Brewer, G. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900338d · Cited by 395
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 290
Vural, H., Demirin, H., Kara, Y., Eren, I., & Delibas, N. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.02.002 · Cited by 235
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 221
Benefits from Dietary Polyphenols for Brain Aging and Alzheimer’s Disease
Rossi, L., Mazzitelli, S., Arciello, M., Capo, C. R., & Rotilio, G. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9696-7 · Cited by 215
Nucleic acid oxidation in Alzheimer disease
Moreira, P. I., Nunomura, A., Nakamura, M., Takeda, A., Shenk, J. C., Aliev, G., Smith, M. A., & Perry, G. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.002 · Cited by 206
Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q.-X., Masters, C. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 195
Smith, D. P., Ciccotosto, G. D., Tew, D. J., Fodero-Tavoletti, M. T., Johanssen, T., Masters, C. L., Barnham, K. J., & Cappai, R. (2007) · Biochemistry · doi:10.1021/bi0620961 · Cited by 194
Copper and Alzheimer's disease
Donnelly, P. S., Xiao, Z., & Wedd, A. G. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.01.678 · Cited by 185
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101473 · Cited by 182
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
Squitti, R., Barbati, G., Rossi, L., Ventriglia, M., Dal Forno, G., Cesaretti, S., Moffa, F., Caridi, I., Cassetta, E., Pasqualetti, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000223343.82809.cf · Cited by 180
Nutritional prevention of cognitive decline and dementia.
Dominguez, L. J., & Barbagallo, M. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i2.7401 · Cited by 166
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
How reliable and robust are current biomarkers for copper status?
Danzeisen, R., Araya, M., Harrison, B., Keen, C. L., Solioz, M., Thiele, D. J., & McArdle, H. J. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507798951 · Cited by 122
Is the Western diet adequate in copper?
Klevay, L. M. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.08.146 · Cited by 121
Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer’s and Parkinson’s diseases
Stelmashook, E. V., Isaev, N. K., Genrikhs, E. E., Amelkina, G. A., Khaspekov, L. G., Skrebitsky, V. G., & Illarioshkin, S. N. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914050022 · Cited by 109
Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., Haber, M., Multhaup, G., Falkai, P., & Pajonk, F.-G. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0080-1 · Cited by 98
Self-citationMocchegiani, E., Costarelli, L., Giacconi, R., Malavolta, M., Basso, A., Piacenza, F., Ostan, R., Cevenini, E., Gonos, E. S., & Monti, D. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.12.007 · Cited by 96
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
Loef, M., & Walach, H. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100376x · Cited by 95
Mocchegiani, E., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., & Malavolta, M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.004 · Cited by 88
Kessler, H., Pajonk, F., Meisser, P., Schneider-Axmann, T., Hoffmann, K.-H., Supprian, T., Herrmann, W., Obeid, R., Multhaup, G., Falkai, P., et al. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0485-7 · Cited by 87
Self-citationMetals in alzheimer's disease: a systemic perspective
Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 84
Alzheimer’s disease as copper deficiency
Klevay, L. M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.051 · Cited by 80
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer’s disease patients
Capo, C. R., Arciello, M., Squitti, R., Cassetta, E., Rossini, P. M., Calabrese, L., & Rossi, L. C. (2007) · BioMetals · doi:10.1007/s10534-007-9125-4 · Cited by 74
Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer disease
Squitti, R., Quattrocchi, C. C., Salustri, C., & Rossini, P. M. (2008) · Prion · doi:10.4161/pri.2.1.6297 · Cited by 69
Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities
Huang, Z., Jordan, J. D., & Zhang, Q. (2023) · Aging and Disease · doi:10.14336/ad.2023.0628 · Cited by 62
Kessler, H., Pajonk, F.-G., Bach, D., Schneider-Axmann, T., Falkai, P., Herrmann, W., Multhaup, G., Wiltfang, J., Schäfer, S., Wirths, O., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0136-2 · Cited by 61
Self-citationTrace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis
Li, K., Li, A., Mei, Y., Zhao, J., Zhou, Q., Li, Y., Yang, M., & Xu, Q. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120782 · Cited by 56
Dietary Patterns and Cognitive Decline: key features for prevention
Dominguez, L. J., Barbagallo, M., Muñoz-Garcia, M., Godos, J., & Martinez-Gonzalez, M. A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190722110458 · Cited by 53
Pickart, L., Vasquez-Soltero, J., & Margolina, A. (2017) · Brain Sciences · doi:10.3390/brainsci7020020 · Cited by 51
Disturbed Copper Bioavailability in Alzheimer′s Disease
Kaden, D., Bush, A. I., Danzeisen, R., Bayer, T. A., & Multhaup, G. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/345614 · Cited by 51
Self-citationLinks between copper and cholesterol in Alzheimer's disease
Hung, Y. H., Bush, A. I., & Fontaine, S. L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00111 · Cited by 46
Metal homeostasis in Alzheimer’s disease
White, A. R., Barnham, K. J., & Bush, A. I. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.711 · Cited by 46
Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimers Disease
Squitti, R., & Salustri, C. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147133 · Cited by 39
Copper in Alzheimer’s disease: too much or too little?
Quinn, J. F., Crane, S., Harris, C., & Wadsworth, T. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.27 · Cited by 38
Han, M., Chang, J., & Kim, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13717 · Cited by 35
Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 34
Moret, V., Laras, Y., Pietrancosta, N., Garino, C., Quéléver, G., Rolland, A., Mallet, B., Norreel, J.-C., & Kraus, J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.026 · Cited by 34
ER chaperone–metal interactions: Links to protein folding disorders
Tiffany‐Castiglioni, E., & Qian, Y. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.007 · Cited by 33
Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients
Squitti, R., Quattrocchi, C. C., Forno, G. D., Antuono, P., Wekstein, D. R., Capo, C. R., Salustri, C., & Rossini, P. M. (2006) · Biomarker Insights · doi:10.1177/117727190600100019 · Cited by 33
Relation between Copper, Lipid Profile, and Cognition in Elderly Jordanians
Al-Khateeb, E. M., Alzayadneh, E. M., Al‐Dalahmah, O., Alawadi, Z., Khatib, F. A., Naffa, R. G., & Shafagoj, Y. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132180 · Cited by 26
Evidence Report: Risk Factor of Inadequate Nutrition
Smith, S. M., Zwart, S. R., & Heer, M. A. (2015) · NASA STI Repository (National Aeronautics and Space Administration) · Cited by 25
Association Between Copper and Global Cognition and the Moderating Effect of Iron
Choe, Y. M., Suh, G., Lee, B. C., Choi, I.-G., Lee, J. H., Kim, H. S., & Kim, J. W. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.811117 · Cited by 24
Anti-Copper Therapies in Alzheimers Disease: New Concepts
Squitti, R., & Zito, G. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104802 · Cited by 21
The Key Role of Oxidative Stress in Alzheimer's Disease
Moreira, P. I., Nunomura, A., Honda, K., Aliev, G., Casadesús, G., Zhu, X., Smith, M. A., & Perry, G. L. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50153-8 · Cited by 21
Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation
Lambert, C., Beraldo, H. D. O., Lievre, N., Garnier‐Suillerot, A., Dorlet, P., & Salerno, M. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0949-1 · Cited by 21
Bayer, T. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.710579 · Cited by 20
Self-citationKatzen-Luchenta, J. (2007) · Nutrition and Health · doi:10.1177/026010600701900212 · Cited by 20
Plant metal chaperones: a novel perspective in dementia therapy
Kastenholz, B., Garfin, D. E., Horst, J., & NAGEL, K. A. (2009) · Amyloid · doi:10.1080/13506120902879392 · Cited by 20
A disease-modifying treatment for Alzheimer’s disease: focus on the trans-sulfuration pathway
Berry, T. M., Hamza, E. A., & Moustafa, A. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0076 · Cited by 15
Role of the Cellular Prion Protein in the Neuron Adaptation Strategy to Copper Deficiency
Urso, E., Manno, D. E., Serra, A., Buccolieri, A., Rizzello, A., Danieli, A., Acierno, R., Salvato, B., & Maffia, M. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9815-5 · Cited by 15
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine
Keskitalo, S., Farkas, M., Hanenberg, M., Szodorai, A., Kulic, L., Semmler, A., Weller, M., Nitsch, R. M., & Linnebank, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00237 · Cited by 14
Traditional Indian Food for Improving Brain Cognition
Choudhury, S. R., Ghosh, J., Koner, S., Singh, K., & Bera, A. (2022) · Acta Scientific Neurology · doi:10.31080/asne.2022.05.0561 · Cited by 13
Oxidative stress and copper smelter workers
Malekırad, A. A., Hassani, S., & Abdollahi, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819092-0.00013-3 · Cited by 9
Hobin, K., Costas‐Rodríguez, M., Wonterghem, E. V., Vandenbroucke, R. E., & Vanhaecke, F. (2023) · Biology · doi:10.3390/biology12060857 · Cited by 9
Can nucleotides prevent Cu-induced oxidative damage?
Baruch-Suchodolsky, R., & Fischer, B. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.11.023 · Cited by 9
Diet, Polyphenols, and Human Evolution
Restani, P., Colombo, F., Biella, S., Bani, C., Mercogliano, F., & Lorenzo, C. D. (2022) · Applied Sciences · doi:10.3390/app12157805 · Cited by 8
HSPA5 Forms Specific Complexes with Copper
Qian, Y., Meng, B., Zhang, X., Zheng, Y., Taylor, R. J., & Tiffany‐Castiglioni, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0923-x · Cited by 7
Lower levels of serum copper in patients with Alzheimer’s dementia: A controlled study from India
Shere, S. S., Subramanian, S., Bharath, S., & Purushottam, M. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.11.036 · Cited by 6
Copper in Brain and Neurodegeneration
Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2143 · Cited by 6
Phytopharmaceuticals In The Therapy Of Younger Alzheimer Patients
Patients, A., & Kastenholz, B. (2011) · Cited by 4
Jamal, R., Dihmis, O. W., Carroll, L. S., & Pengas, G. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-239375 · Cited by 4
Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
Dominguez, L. J., & Barbagallo, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00015-8 · Cited by 4
Deepika, D., Kumar, J., Ali, S. A., Namdeo, A. G., & Flora, S. J. S. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127929 · Cited by 3
Metals and Mitochondria in Neurodegeneration
Plascencia‐Villa, G., José–Yacamán, M., & Perry, G. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00015-4 · Cited by 3
How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.
Danzeisen, R., Araya, M., Harrison, B., Keen, C. L., Solioz, M., Thiele, D. J., & McArdle, H. J. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508958025 · Cited by 3
Iron and Copper in Alzheimer’s Disease
Loef, M., & Walach, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00052-5 · Cited by 2
Chapter Six - Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Giorgi, C., Marchi, S., Simoes, I., Ren, Z., Morciano, G., Perrone, M., Patalas‐Krawczyk, P., Borchard, S., Jędrak, P., Pierzynowska, K., et al. (2018) · UCL Discovery (University College London) · Cited by 2
Can Plant-Made Copper Chaperones Heal Early Alzheimer’s Disease?Preprint
Kastenholz, B., Horst, B. A. J., & Horst, J. (2011) · Nature Precedings · doi:10.1038/npre.2011.5907.9 · Cited by 2
Obomsawin, A., Furlano, J. A., Ferrow, L., Morrow, D., Ferland, G., Middleton, L. E., Crowshoe, L. L., Walker, J. D., & Fiocco, A. J. (2025) · Canadian Journal of Public Health · doi:10.17269/s41997-025-01078-6 · Cited by 1
Ventura, J., Roell, L., Maurus, I., & Firth, J. (2026) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgag006 · Cited by 1
Copper's Role in Alzheimer Disease Strengthened by New Study
Hurley, D. (2008) · Neurology Today · doi:10.1097/01.10149.0000309784.01135.3e · Cited by 1
Copper and Alzheimer Disease: The Good, the Bad and the Ugly
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_30 · Cited by 1
Metals Involvement in Alzheimer’s Disease Pathogenesis
Squitti, R., & Salustri, C. (2011) · InTech eBooks · doi:10.5772/16880 · Cited by 1
Alzheimer Disease: Oxidative Stress and Compensatory Responses
Moreira, P. I., Nunomura, A., Zhu, X., Lee, H., Aliev, G., Smith, M. A., & Perry, G. L. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_7 · Cited by 1
López, N. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Kollalpitiya, K. Y. (2011) · Holmes Museum Of Anthropology (Wichita State University)
The role of the E2 copper binding domain in the cell biology of the amyloid precursor protein
Blanthorn-Hazell, S. (2015) · Lancaster EPrints (Lancaster University)
Choe, Y. M., Suh, G.-H., Lee, B. C., Choi, I.-G., Lee, J. H., Kim, H. S., & Kim, J. W. (2022) · doi:10.3389/fnagi.2022.811117.s001
Metadata
- Authors
- Pajonk, F.-G., Kessler, H., Supprian, T., Hamzei, P., Bach, D., Schweickhardt, J., Herrmann, W., Obeid, R., Simons, A., Falkai, P., Multhaup, G., & Bayer, T. A.
- Affiliations
- Saarland University (DE)
- Universitätsklinikum des Saarlandes (DE)
- Freie Universität Berlin (DE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2005-09-09
- Volume
- 8
- Issue
- 1
- Pages
- 23-27
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W130613403
- Cited by
- 83
- References
- 20
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 7
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- International Copper Association
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, copper
- MeSH terms
- Aged, Alzheimer Disease, Ceruloplasmin, Cognition Disorders, Copper, Female, Humans, Male, Neuropsychological Tests, Psychometrics, Statistics as Topic, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.